Lung cancer – the deadliest form of cancer

As one of the most common types of cancer, lung cancer (bronchial carcinoma) is also particularly deadly. It is the second leading cause of cancer-related death for women, with numbers on the rise, and the leading cause of cancer deaths for men. One key reason is that the disease is often diagnosed at a very late stage, by which time it has typically advanced significantly. In its early stages, tumors can usually be removed surgically. Patients for whom surgery is not an option may undergo chemotherapy.

Noticeable symptoms of lung cancer typically appear late and are nonspecific, which means that the symptoms may mistakenly be attributed to bronchitis. The most common symptoms include persistent coughing, shortness of breath, mucus production, lung and chest pain, general weakness/fatigue, weight loss, bone pain, fever, and neurological symptoms such as headaches.

The primary risk factor for lung cancer is still smoking, which is estimated to cause around 85% of all cases.

Genetic influence on our lung cancer risk

In everyday life, our lungs are continuously exposed to harmful environmental factors, such as vehicle and industrial emissions. Normally, our immune system identifies and neutralizes these dangers in time.

However, for many people, certain genetic variations prevent their detoxification system from functioning properly, which significantly increases the risk of bronchial carcinoma over time. A genetic analysis can be helpful in identifying potential risks early and taking action, such as quitting smoking, to counteract them in time.

How does our Lung Health Sensor work?

With our Lung Health Sensor, our laboratory analyzes the submitted saliva sample for five genetic variants that can increase the likelihood of lung cancer. This genetic test helps us determine how likely a person is to develop lung cancer.

We also assess how the genetic profile affects the tolerance and efficacy of 40 relevant medications.

The analysis results are compiled in a clear report that includes additional preventive recommendations if necessary.

In this context, our Lung Health Sensor can contribute significantly to the early detection of lung cancer and help reduce risks through effective preventive measures.

Lung Health Sensor Overview

  • Analysis of 5 genetic variations associated with lung cancer
  • Risk assessment for developing lung cancer
  • Effectiveness test for 40 common medications
  • Reliable & ISO-certified testing in our laboratory
  • Comprehensive evaluation of test results
  • Individual recommendations for preventing lung cancer

DEMO – Lung Health Sensor

Here you can view a demo analysis!

Once your genetic analysis is successfully completed and reviewed by a scientist, the data will be compiled into a comprehensive report – similar to the demo shown here. The scientific background information on the genes, along with the laboratory results, will be published in this report.

Having trouble viewing? Please download the PDF with the download icon in the player!

Other ProMedicDNA analyses